Precision medicine is an approach to healthcare that tailors prevention, diagnosis and treatment to the unique biological and environmental characteristics of each person. It contrasts with traditional “one size fits all” strategies by integrating genetic information, molecular profiles, lifestyle, environment and clinical data to guide decisions.

A central element is genomic medicine. Sequencing a patient’s DNA can identify variants that influence disease risk, prognosis and drug response. In oncology, tumors are profiled to detect specific mutations or molecular signatures. Therapies are then chosen to target those alterations, improving effectiveness and reducing unnecessary toxicity. This has transformed treatment for several cancers, where patients are selected for drugs based on markers such as receptor status, gene fusions or mutational profiles.

Beyond cancer, precision medicine is expanding into cardiovascular disease, rare genetic disorders, metabolic disease and pharmacogenomics. Genetic and molecular markers can help predict who is at high risk, who will benefit from a given drug and who is likely to experience side effects. Large population studies combine genomic, clinical and lifestyle data to refine risk prediction and uncover new therapeutic targets.

Implementing precision medicine requires advanced diagnostics, robust data infrastructure and tools such as machine learning to interpret complex datasets. Ethical and social issues are central, including privacy of genetic data, equitable access to testing and therapies, and avoiding disparities in who benefits from these advances.

Overall, precision medicine aims to deliver more accurate diagnoses, more effective and safer treatments, and earlier, more targeted prevention by aligning medical care with the specific characteristics of each individual.